In the News

EvergreenHealth was awarded a $10,000 grant from the Michael J. Fox Foundation (MJFF) for Parkinson's Research

Read about the grant >

FDA Approves US WorldMeds' MYOBLOC® (rimabotulinumtoxinB) Injection for Chronic Sialorrhea

August 2019

Novartis ofatumumab demonstrates superiority versus Aubagio® in two head-to-head Phase III multiple sclerosis studies

August 2019

APDA Research Symposium

April 2019

EvergreenHealth Neurologist and Parkinson's expert Dr. Pinky Agarwal participated in the researcher panel: